Priority Review Granted to Novel Pneumococcal Conjugate Vaccine V114
The V114 vaccine candidate consists of pneumococcal polysaccharides from 15 serotypes, including serotypes 22F and 33F, which are associated with invasive pneumococcal disease.
Bacterial Infections
New Drugs Approved in 2020
Visit our New Drug Products page to stay up-to-date on the latest drug approvals.
New Guidelines for the Management of Lyme Disease
The Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology provided new clinical practice guidelines for Lyme disease prevention, diagnosis, and treatment.
Reltecimod Under Review for Organ Dysfunction/Failure With Necrotizing Soft Tissue Infection
The drug is designed to modulate the acute inflammatory response observed in patients with NSTI that leads to organ dysfunction or failure.
Priority Review Granted to 20-Valent Pneumococcal Conjugate Vaccine
The 20vPnC vaccine candidate consists of capsular polysaccharide conjugates for the 13 serotypes included in Prevnar 13, along with 7 additional serotypes that cause invasive pneumococcal disease.
Possible Microbial Contamination Prompts Recall of Oral Rinse
Paroex Chlorhexidine Gluconate Oral Rinse is indicated for the treatment of gingivitis.
CDC Warns of Multistate Listeria Outbreak
All 10 infected people were hospitalized; one death reported in Florida.
When Settling a Lawsuit Is the Smartest Move
There are many reasons why parties to a lawsuit decide to settle.
MPR Weekly Dose Podcast Episode 55
Results from the survey assessing willingness to receive a COVID vaccine; Dr. Fauci shares that he is ‘cautiously optimistic’ a vaccine could arrive before year’s end; And the breaking news that remdesivir (Veklury) has gained FDA approval.
Novel Pneumococcal Conjugate Vaccine Immunogenic in Phase 3 Trials
Results from PNEU-PATH demonstrated comparable immune responses following vaccination with Pneumovax 23 in both treatment groups for the 15 serotypes in V114.
